Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S(2024) CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia Cell Rep Med, 5(6), 101572 DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Wu C, Gunnarsson EB, Myklebust EM, Köhn-Luque A, Tadele DS, Enserink JM, Frigessi A, Foo J, Leder K(2024) Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data PLoS Comput Biol, 20(3), e1011888 DOI 10.1371/journal.pcbi.1011888, PubMed 38446830
Corrales J, Ramos-Alonso L, González-Sabín J, Ríos-Lombardía N, Trevijano-Contador N, Engen Berg H, Sved Skottvoll F, Moris F, Zaragoza O, Chymkowitch P, Garcia I, Enserink JM(2024) Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole Microbiol Spectr, 12(2), e0259423 DOI 10.1128/spectrum.02594-23, PubMed 38230926
Department of Molecular Cell Biology, Institute for Cancer Research The Norwegian Radium Hospital, Montebello, N-0379 Oslo, Norway Telephone +47 22 78 19 82 (Enserink), +47 22 78 12 69 (Dept. Secretary) Email: jorrit.enserink@rr-research.no